BioShai is developing PDx, a simple blood test for the early diagnosis of Parkinson’s disease. The blood test can be combined with other clinical data to provide a more complete diagnosis to help physicians decide on the best course of treatment.
Parkinson's Disease Diagnosis
The diagnosis of Parkinson's is mainly based on patients' medical history and clinical examination. In some cases Parkinson's disease can be difficult to diagnose with early signs and symptoms being dismissed as the effects of normal aging.
PDx - Pioneering Research
A European and Israeli study performed at the lab of Prof. Moussa Youdim, one of the inventors of Teva’s Parkinson’s drug Rasagiline (Azilect), revealed that the expression level of 5 genes in blood can detect Parkinson’s disease (PD). Published findings show high diagnostic accuracy of 90%-100% for discerning PD patients from healthy controls and from Alzheimer patients. Building on this research BioShai’s expert team is commercializing the PDx assay.
PDx the First
Blood Test for Parkinson's Diagnosis
Get a clear objective diagnosis.
Expected availability in 2018.
PDx is based on the measurement of the level of expression of a set of genes. Gene expression is a dynamic process affected by stress, diet, and health leading to dramatic changes in the amount of messenger RNA molecules and protein in the human body over the course of our lives.